| __timestamp | Bio-Techne Corporation | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 520990000000 |
| Thursday, January 1, 2015 | 144969000 | 535405000000 |
| Friday, January 1, 2016 | 162364000 | 558755000000 |
| Sunday, January 1, 2017 | 188462000 | 495921000000 |
| Monday, January 1, 2018 | 210850000 | 659690000000 |
| Tuesday, January 1, 2019 | 240515000 | 1089764000000 |
| Wednesday, January 1, 2020 | 255497000 | 994308000000 |
| Friday, January 1, 2021 | 298182000 | 1106846000000 |
| Saturday, January 1, 2022 | 349103000 | 1244072000000 |
| Sunday, January 1, 2023 | 366887000 | 1431505000000 |
| Monday, January 1, 2024 | 389335000 | 1431505000000 |
Data in motion
In the ever-evolving pharmaceutical and biotech industries, understanding cost efficiency is crucial. Takeda Pharmaceutical Company Limited and Bio-Techne Corporation, two giants in their respective fields, offer a fascinating study in contrasts. Over the past decade, Takeda's cost of revenue has surged by approximately 175%, reaching a staggering 1.43 trillion in 2023. In contrast, Bio-Techne's cost of revenue grew by about 266%, yet remains a fraction of Takeda's, at 389 million in the same year.
This disparity highlights the scale and operational differences between a pharmaceutical behemoth and a biotech innovator. While Takeda's vast operations drive higher costs, Bio-Techne's leaner model reflects its niche focus. Investors and industry watchers should consider these dynamics when evaluating cost efficiency and strategic growth. As the landscape shifts, these insights could inform future investment and operational strategies.
Cost of Revenue Comparison: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
Pfizer Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: GSK plc vs Bio-Techne Corporation
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs CRISPR Therapeutics AG
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Teva Pharmaceutical Industries Limited vs Bio-Techne Corporation
Cost of Revenue Comparison: Viatris Inc. vs Bio-Techne Corporation
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Bio-Techne Corporation
Cost of Revenue Trends: Bio-Techne Corporation vs Corcept Therapeutics Incorporated
Cost of Revenue Trends: Bio-Techne Corporation vs MorphoSys AG